在患有急性淋巴细胞白血病的孩子中，有一些证据表明，女孩比男孩更可能有长期认知问题。
In children with acute lymphoblastic leukemia, there is some evidence to suggest that girls are more likely to have long-term cognitive problems than boys.
急性淋巴细胞性白血病也称急性淋巴母细胞性白血病，又称急性儿童期白血病。
Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
这项研究中，研究者回顾了十四项发表的研究，涉及全世界近两万儿童，其中三分之一患有急性淋巴细胞白血病。
The researchers reviewed 14 published studies of nearly 20, 000 children worldwide, about a third of whom had acute lymphoblastic leukemia.
急性淋巴细胞性白血病是儿童最为常见的癌症，而且治疗能带来疾病治愈的好机会(译者：指治愈希望较大)。
Acute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure.
急性淋巴细胞性白血病(all)是一种发生于血液和骨髓的癌症——骨髓(译者：此处指红骨髓)是指作为造血场所的骨内的海绵组织。
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.
急性淋巴细胞白血病和急性粒细胞性白血病均由癌变的母细胞引起，如淋巴母细胞或原始粒细胞。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
恶性淋巴增生包括淋巴瘤、急性淋巴细胞白血病和慢性淋巴细胞白血病。
Lymphoproliferative malignancies include lymphomas and acute lymphoblastic and chronic lymphocytic leukemias.
这是最常见的一种白血病，占儿童白血病的大约百分之八十。每百万儿童中，有二十到三十个会得急性淋巴细胞白血病。
This is the most common form of the disease and accounts for about 80 percent of all childhood leukemias.
她被吓坏了，也没有心思听肿瘤学家说什么“急性淋巴细胞白血病经常可以治愈”的话了。
She's terrified, and she may not be in a state of mind to take in the oncologist's reassurance that A.L.L. is "often curable."
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
别名有，急性淋巴母细胞性白血病和急性淋巴性白血病。
Other names for ALL are acute lymphoblastic leukemia and acute lymphoid leukemia.
在高浓度，筹备工作已经表明，以抑制急性淋巴细胞白血病和急性粒细胞白血病细胞。
In high concentrations, preparations have shown to inhibit cells from acute lymphocytic and acute granulocytic leukemia.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
目的：通过血药浓度监测，提高对小儿急性淋巴细胞白血病大剂量甲氨蝶呤化疗的有效性和安全性。
OBJECTIVE: to improve the efficacy and safety of high dose methotrexate (HDMTX) chemotherapy in the treatment of children with acute lymphoblastic leukemia through blood concentration monitoring.
急性淋巴细胞白血病具有恶性程度高、复发率高、多重耐药、预后差等特点，其治疗存在较大困难。
Acute lymphoblastic leukemia with a high degree of malignancy, recurrence rate, multi-drug resistance, poor prognosis features, there is a greater difficulty in its treatment.
目的探讨CYP1A1基因多态性与急性淋巴细胞白血病（ALL）遗传易感性的关系。
Objective: To study the possible relationship between CYP1A1 genetic polymorphisms and susceptibility of acute lymphoblastic leukemia(ALL).
目的探索提高急性淋巴细胞白血病(all)微量残留病(MRD)检测技术。
Objective To improve the techniques for minimal residual disease (MRD) detection in acute lymphoblastic leukemia (ALL).
目的研究急性淋巴细胞性白血病(all)免疫表型的特点。
Objective To study the character of immunophenotype in acute lymphoblastic leukemia (ALL).
靶向基因治疗在化疗过程中取得明显效果，现将近年来靶向基因治疗急性淋巴细胞白血病的研究进展综述如下。
Targeted gene therapy in the course of chemotherapy has achieved remarkable results, now in recent years, targeted gene therapy of acute lymphoblastic leukemia research are summarized below.
目的：探讨小儿急性淋巴细胞白血病(all)的治疗效果。
Objective: To explore the curative effect of children with acute lymphoblastic leukemia (ALL).
目的研究儿童急性淋巴细胞白血病(all)染色体变化，探讨其临床意义。
Objective To analyze the chromosomal changes and its clinical significance in childhood acute lymphoblastic leukemia (ALL).
系急性淋巴细胞性白血病(all)为出现于儿童与青少年的最常见的癌症。
B-lineage acute lymphoblastic leukemia (ALL) is the most common cancer occurring in children and adolescents.
目的研究急性淋巴细胞性白血病(all)中免疫表型的特点。
Objective To study the feature of immunophenotype in acute lymphoblastic leukemia (ALL).
目的：探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。
Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.
目的探讨儿童急性淋巴细胞白血病(all)免疫表型与无病生存期(EFS)的关系。
Objective To investigate the relationship between immunophenotype and event-free survival (EFS) in children with acute lymphoblastic leukemia (ALL).
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
目的利用三色流式细胞术对急性淋巴细胞白血病(all)免疫表型跨系表达进行研究。
Objective to study the cross-lineage expression of acute lymphoblastic leukemia (ALL) with the use of multi-parameter flow cytometry in the immunophenotype of ALL.
目的利用三色流式细胞术对急性淋巴细胞白血病(all)免疫表型跨系表达进行研究。
Objective to study the cross-lineage expression of acute lymphoblastic leukemia (ALL) with the use of multi-parameter flow cytometry in the immunophenotype of ALL.
应用推荐